FDA NDC Directory · JSON-LD · Markdown

EVDI

NDC 60505-6423 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION, CONCENTRATE

Generic nameTrabectedin
Labeler / ManufacturerApotex Corp.
Marketing categoryNew Drug Application (innovator) · App NDA220837
Dosage form / routeINJECTION, SOLUTION, CONCENTRATE · INTRAVENOUS
Active ingredientsTRABECTEDIN (.05 mg/mL)
Marketing started20260630
Package count1

External sources

Source: openFDA. Public-domain (CC0).